Laraway Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Laraway Financial Advisors's PFE Position: Q2 2026 in Review
Laraway Financial Advisors held its Pfizer (PFE) position steady in Q2 2026 at 7,159 shares worth $172K. The position accounts for 0.1% of the portfolio, ranked #137.
Laraway Financial Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $650K in Q4 2021. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Laraway Financial Advisors held 7,159 shares of Pfizer worth $172K as of Q2 2026.
- Laraway Financial Advisors left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.1% of Laraway Financial Advisors's portfolio in Q2 2026, its #137 holding.
- Laraway Financial Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Laraway Financial Advisors's Pfizer position peaked at $650K in Q4 2021.
- 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Laraway Financial Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.